Summit Therapeutics
SMMT
#1525
Rank
HK$106.04 B
Marketcap
HK$142.45
Share price
-2.66%
Change (1 day)
-1.87%
Change (1 year)

Revenue for Summit Therapeutics (SMMT)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Summit Therapeutics from 2017 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A-100%
2022 HK$5.5 M-60.95%
2021 HK$14.1 M
2019 HK$11.28 M-98.13%
2018 HK$0.60 B211.79%
2017 HK$0.19 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Sarepta Therapeutics
SRPT
HK$18.77 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
HK$2.9 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
HK$0.65 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA